Mind Medicine (MindMed)
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mind Medicine (MindMed) generated cash of -$64,365,000, which is less than the previous year. Cash used in financing activities reached the amount of $21,848,000 last year. Net change in cash is therefore -$42,438,000.
Cash Flow
| 2015 | -46.55K | 41.86K | 0 |
|---|---|---|---|
| 2017 | -665.98K | -3.67M | 4.35M |
| 2019 | -208.11K | -213.15K | 288.36K |
| 2020 | -23.59M | 0 | 96.70M |
| 2021 | -45.82M | -297K | 98.82M |
| 2022 | -50.13M | 0 | 59.05M |
| 2023 | -64.36M | 0 | 21.84M |
MNMD Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 142.14M | 133.53M | 80.09M | 6.70M | 154.79K | 10.96K | 9.31K |
Operating activities | |||||||
Net income | -95.73M | -56.79M | -93.03M | -33.93M | -1.11M | -1.22M | -92.65K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 3.16M | 3.18M | 2.61M | 0 | 6.68K | 5.5K | 0 |
Stock-based compensation expense | 15.49M | 13.70M | 42.71M | 7.40M | 0 | 0 | 0 |
| Deferred income tax benefit | 15.49M | 13.70M | 42.71M | 7.40M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | -13K | 3.01K | -4.91K | -98 |
Inventories | 0 | 0 | 0 | 13K | 0 | 0 | 0 |
Accounts payable | 2.02M | -2.05M | 1.28M | 544K | 0 | 0 | 0 |
Cash generated by operating activities | -64.36M | -50.13M | -45.82M | -23.59M | -208.11K | -665.98K | -46.55K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -1.55M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -313.45K | -2.14M | 0 |
Acquisitions Net | 0 | 0 | -297K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -297K | 0 | -213.15K | -3.67M | 41.86K |
Financing activities | |||||||
Common Stock Issued | 7.52M | 42.29M | 81.92M | 71.99M | 288.36K | 4.33M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 14.15M | 0 | 0 | 0 | 0 | 14.94K | 0 |
Cash used in financing activities | 21.84M | 59.05M | 98.82M | 96.70M | 288.36K | 4.35M | 0 |
Net Change In Cash | -42.43M | 8.60M | 53.44M | 73.39M | -136.86K | -6.98K | -4.69K |
Cash at end of period | 99.70M | 142.14M | 133.53M | 80.09M | 17.93K | 3.97K | 4.62K |
| Data source | Data source | Data source |